NEWPORT NEWS, Va., Nov. 16 /PRNewswire/ Dilon Technologies, Inc. a United States manufacturer and supplier of high-resolution molecular imaging systems announces the hiring of Scott Yarde for the position of Vice President (VP) of Sales and Business Development.
Scott Yarde joins Dilon to provide leadership in national sales and business development objectives. Yarde brings a proven track record with 25 years of sales, marketing and senior level management experience; including VP of Sales and Marketing with Fischer Imaging Corporation, from where he later transitioned with the acquisition of Fisher to Director of Southwest Regional Sales for Hologic. Previous to this, Yarde was the Director of Ultrasound Marketing for Toshiba America Medical Systems, where he developed and launched marketing campaigns to support new product introductions.
A seasoned professional in medical imaging, particularly women's imaging, Yarde's substantial experience will be leveraged to meet the challenging balance of building market segments for conceptual medical procedures.
"We are excited about this new phase of growth and expansion," said Dilon's CEO, Lon Slane. "Scott Yarde will complement our executive team and help us achieve the aggressive goals and vision that we have planned."
About Dilon Technologies
Dilon Technologies is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Northwestern Memorial Hospital, Chicago; and The Rose, Houston. For more information on Dilon Technologies please visit http://www.dilon.com.
|SOURCE Dilon Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved